Progression and new onset of nonalcoholic fatty liver disease in living kidney donors compared to healthy controls

מאת: Katchman H., Zelber-Sagi S., Baruch R., Berman G., Schwartz I.F., Schwartz D., Nakache R., Goykhman Y., Katz P., Shibolet O., Shashar M., Grupper A.
פורסם ב: Clinical Transplantation
תיאור: Background: There is growing evidence linking nonalcoholic fatty liver disease (NAFLD) with reduced glomerular filtration rate (GFR). Living kidney donors do not have underlying kidney disease, but have reduced GFR as a result of nephrectomy. Whether kidney donation is associated with a higher risk for development or progression of NAFLD is currently unknown. Methods: Retrospective evaluation of metabolic parameters and sonographic evidence of NAFLD were performed in 232 living kidney donors and 162 healthy controls. Results: A total of 25 donors and 44 controls had NAFLD at baseline. During a mean follow-up of 6.8 years, 6 donors (24%) and 17 controls (38.6%) (P =.29) had a remission of NAFLD, related with decreased body mass index (BMI). The progression of NAFLD fibrosis score was similar in both groups. New onset of NAFLD was observed in 14 (6.8%) donors and 13 (11.01%) controls (P =.211), and was related to increased BMI and a higher baseline Fatty Liver Index score. Neither eGFR nor urine albumin excretion in the donors were related to new onset or progression of NAFLD. Conclusions: Reduced kidney function secondary to kidney donation is not associated with increased incidence or progression of NAFLD. © 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd
SDGs : SDG 03  |  יחידות: מדעי הרווחה והבריאות  | מועד: 2018 |  קישור